New York · Nonprofit
AMERICAN-ITALIAN CANCER FOUNDATION
AMERICAN-ITALIAN CANCER FOUNDATION (New York) receives grants from 44 organizations whose IRS filings report $7,327,671 to it, the largest being JEWISH COMMUNAL FUND ($1,154,000). 25 of them have funded it in more than one year, and 51% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2025
- $3.2M
- Funders on record
- 44
- Grants received
- $7.3M
- Net assets
- $8.1M
What American-Italian Cancer Foundation does
Mission
To support cancer research, education and early detection, (cont. On schedule o)emphasizing the unique resources of italy & usa, recognizing world-class scientific excellence in medicine.
As stated on its FY2025 Form 990.
Programs
On its FY2024 return the organization reported starting a significant new program.
A mobile, no-cost prostate cancer screening service was launched. Aicf now offers free psa testing in nyc medically-underserved communities to promote prostate cancer early detection.
Its own explanation, from Schedule O of that return (Part III, line 2).
Cancer screening: mobile no-cost breast cancer screening program- provides mobile breast cancer screening, outreach and education to economically disadvantaged and medically underserved women in new york city. Mobile no-cost prostate cancer screening program- provides mobile free psa testing to economically disadvantaged and medically underserved men in new york city to promote prostate cancer early detection.
$929,989 spent47% of program spendingFellowship research awards - provides financial support for the post-doctoral research of promising young scientists who pursue research and advanced training in collaboration with mentors at major cancer centers in the us.
$892,654 spentof which $783,981 as grants45% of program spendingCancer education and awards - the prize for scientific excellence in medicine has been established to recognize important discoveries in cancer biology, prevention, diagnosis and/or treatment. It is awarded in two categories: excellence in basic science and excellence in clinical oncology. Each winner is awarded $50,000. Occasionally, a special recognition award of $25,000 is also presented to recognize scientific excellence in a different category.
$154,564 spentof which $131,910 as grants8% of program spending
The 3 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $1,977,207.
The organization over time
Each line starts at 100 in 2018, so what you read is the shape rather than the size: 150 means half as much again as 2018, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2024 to 2025, from $6.9M to $8.3M (+21%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2018 19% · 2019 25% · 2020 23% · 2021 22% · 2022 30% · 2023 24% · 2024 23% · 2025 15%. Grants only. Government contracts and fees sit inside program revenue.
79% of AMERICAN-ITALIAN CANCER FOUNDATION’s revenue is contributions — more donation-reliant than the typical peer (51% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 0 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Cristina Aibino
Executive director
Board chair
Daniele D Bodini
Chairman
As listed on its FY2025 Form 990.
Who funds it, year by year
2017 → 2023: the base broadened from 13 funders to 18 funders, grant income rose $616k → $1.3M.
9 of 44 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 51% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of AMERICAN-ITALIAN CANCER FOUNDATION’s funders (the co-funder graph). Top 30 of 44 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
AMERICAN-ITALIAN CANCER FOUNDATION has a broad base — no single funder exceeds 16% of grant income, and it takes 4 funders to reach half.
the vertical line marks half of all grant income — 4 funders to its left
61% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund AMERICAN-ITALIAN CANCER FOUNDATION.
Largest funder’s share by year: 2017 28% · 2018 16% · 2019 19% · 2020 18% · 2021 25% · 2022 40% · 2023 31% — growing more concentrated.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
43% of AMERICAN-ITALIAN CANCER FOUNDATION's funders are still giving 3 years after their first grant; 57% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
51% of AMERICAN-ITALIAN CANCER FOUNDATION's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $3.6M that is directly attributable, 55% of it comes from New York funders.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $3.7M arriving through sponsors registered in 7 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
AMERICAN-ITALIAN CANCER FOUNDATION runs a healthier operating margin than three-quarters of the 4,665 health nonprofits its size.
this organization peer median middle 50% of peers· 4,665 health nonprofits $1M–$10M, FY2025
Organizations like AMERICAN-ITALIAN CANCER FOUNDATION
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In New York
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
96% of spending goes to programs.
Governance
Public support
81%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for AMERICAN-ITALIAN CANCER FOUNDATION: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds AMERICAN-ITALIAN CANCER FOUNDATION?
- AMERICAN-ITALIAN CANCER FOUNDATION (New York) receives grants from 44 organizations whose IRS filings report $7,327,671 to it, the largest being JEWISH COMMUNAL FUND ($1,154,000). 25 of them have funded it in more than one year, and 51% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does AMERICAN-ITALIAN CANCER FOUNDATION have?
- IRS filings report 44 organizations giving $7,327,671 in grants to AMERICAN-ITALIAN CANCER FOUNDATION, 25 of which have funded it in more than one year.
- Who is the largest funder of AMERICAN-ITALIAN CANCER FOUNDATION?
- JEWISH COMMUNAL FUND is the largest funder on record, with $1,154,000 in grants. The full list of funders is on this page.
- How can an organization like AMERICAN-ITALIAN CANCER FOUNDATION find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in New York. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2018–2025), and the filings of 44 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing